Immatics Biotechnologies GmbH - Company Profile
Powered by 
All the data and insights you need on Immatics Biotechnologies GmbH in one report.
$295
- Save hours of research time and resources with
our up-to-date Immatics Biotechnologies GmbH Strategy Report
- Understand Immatics Biotechnologies GmbH position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Immatics Biotechnologies GmbH’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Immatics Biotechnologies GmbH's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Harpreet Singh, Ph.D.
Chief Executive Officer Senior ManagementDr. Harpreet Singh has been the Chief Executive Officer and Managing Director of Immatics since 2019. Prior to this, he was the Chief Scientific Officer of the company. Currently, Dr. Singh also serves as the President and Chief Executive Officer of Immatics US Inc.
Cedrik Britten
Chief Medical Officer Senior ManagementMr. Cedrik Britten has been the Chief Medical Officer of the company since 2020. Prior to this role, he served as Vice President and Head of the Oncology Cell Therapy Research Unit at GlaxoSmithKline. Prior to that, he held various senior positions at BioNTech including Vice President for R&D.
Rainer Kramer, Ph.D.
Chief Business Officer Senior ManagementDr. Rainer Kramer has been the Chief Business Officer of Immatics since 2012. Prior to this, he was Chief Business Officer for Signature Diagnostics AG. Dr. Kramer also worked in various business development functions at Jerini AG, MorphoSys AG, Martinsried and Amgen Inc.
Carsten Reinhardt, M.D. Ph.D
Chief Development Officer Senior ManagementDr. Carsten Reinhardt has been the Chief Development Officer of the company since 2020. Prior to this role, Carsten served as Chief Medical Officer and Managing Director of Immatics since 2009. Prior to this, he worked as a Chief Medical Officer at Micromet, Inc. Dr. Reinhardt was also the International Medical Leader for Herceptin at Hoffmann-La Roche and Head of Clinical Development at Fresenius Biotech.
Steffen Walter, Ph.D.
Chief Operating Officer Senior ManagementStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer